Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia tre...
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol
About this item
Full title
Author / Creator
Interfant-99 Study Group , Van der Velden, V H J , Corral, L , Valsecchi, M G , Jansen, M W J C , De Lorenzo, P , Cazzaniga, G , Panzer-Grümayer, E R , Schrappe, M , Schrauder, A , Meyer, C , Marschalek, R , Nigro, L L , Metzler, M , Basso, G , Mann, G , Den Boer, M L , Biondi, A , Pieters, R and Van Dongen, J J M
Publisher
London: Nature Publishing Group UK
Journal title
Language
English
Formats
Publication information
Publisher
London: Nature Publishing Group UK
Subjects
More information
Scope and Contents
Contents
Acute lymphoblastic leukemia (ALL) in infants younger than 1 year is a rare but relatively homogeneous disease (∼80%
MLL
gene rearranged, ∼70% CD10-negative) when compared with childhood and adult ALL. Several studies in children and adults with ALL have shown that minimal residual disease (MRD) status is a strong and independent prognostic f...
Alternative Titles
Full title
Prognostic significance of minimal residual disease in infants with acute lymphoblastic leukemia treated within the Interfant-99 protocol
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_67353792
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_67353792
Other Identifiers
ISSN
0887-6924
E-ISSN
1476-5551
DOI
10.1038/leu.2009.17
